Industry reports
Editor highlights

Chiral Technology International Technology Market Trends

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Search ReportLinker

The Largest Collection of Market Research Reports

» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides

From +200,000 authoritative sources

DOWNLOAD THESE REPORTS NOW!

Clinical Trial Management System Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2019

Clinical Trial Management System Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2019

  • $ 4 795
  • Industry report
  • by Transparency Market Research
  • April 2014
  • 113 pages

Clinical trial management system (CTMS) is a software solution for proper management, storage and analysis of drugs associated clinical data. CTMS is primarily employed to manage large amount of data involved in a clinical trial including planning, preparation and reporting. CTMS also provides data to ...

Industries: Drug Discovery and Development | Countries: World, United States, South Korea, Europe, Asia, Poland, France, Germany, China

OpportunityAnalyzer: Pancreatic Cancer - Opportunity Analysis and Forecasts to 2017

OpportunityAnalyzer: Pancreatic Cancer - Opportunity Analysis and Forecasts to 2017

  • $ 5 995
  • Industry report
  • by Global Data
  • March 2014
  • 179 pages

OpportunityAnalyzer: Pancreatic Cancer - Opportunity Analysis and Forecasts to 2017 Summary With five-year survival only approximately 5%, pancreatic cancer is characterized as a disease with some of the highest unmet need in oncology. This report focuses on the current treatment landscape, unmet needs, ...

Industries: Pathology | Countries: United States, World, Europe, Spain, Italy, France, Germany

EpiCast Report: Ankylosing Spondylitis - Epidemiology Forecast to 2022

EpiCast Report: Ankylosing Spondylitis - Epidemiology Forecast to 2022

  • $ 3 995
  • Industry report
  • by Global Data
  • March 2014
  • 49 pages

EpiCast Report: Ankylosing Spondylitis - Epidemiology Forecast to 2022 Summary Ankylosing spondylitis is a systemic, chronic, and progressive inflammatory arthritis in the family of seronegativespondyloarthritis, and is one of the most common rheumatic conditions throughout the world. Ankylosing spondylitis ...

Industries: Pathology | Countries: World, United States, Japan, Europe, Sweden, Spain, Italy, France, Germany, Finland

immatics biotechnologies GmbH - Strategic SWOT Analysis Review

immatics biotechnologies GmbH - Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • by Global Data
  • March 2014
  • 24 pages

immatics biotechnologies GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products ...

Industries: Pathology | Countries: Switzerland, Denmark, Europe, United States

Elekta AB (EKTA B) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Elekta AB (EKTA B) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • by Global Data
  • March 2014
  • 21 pages

Summary Elekta AB (Elekta) is a medical technology company. The company offers advanced clinical solutions, comprehensive information systems and services for the management of brain disorders and improved cancer care. The company classifies its products into four categories, namely, neuroscience, oncology, ...

Industries: Pathology | Countries: Sweden, Netherlands, World, Europe

PharmaPoint: Schizophrenia - 5EU Drug Forecast and Market Analysis to 2022

PharmaPoint: Schizophrenia - 5EU Drug Forecast and Market Analysis to 2022

  • $ 6 995
  • Industry report
  • by Global Data
  • February 2014
  • 166 pages

PharmaPoint: Schizophrenia - 5EU Drug Forecast and Market Analysis to 2022 Summary Schizophrenia is a persistent long-term brain disorder that causes severe, debilitating psychotic episodes. Its core symptoms, auditory or visual hallucinations, are often accompanied by fixed, false, and often paranoid ...

Industries: Pathology | Countries: Germany, Spain, Italy, France, United Kingdom, Europe

Seroquel (Schizophrenia) - Forecast and Market Analysis to 2022

Seroquel (Schizophrenia) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • by Global Data
  • February 2014
  • 43 pages

Seroquel (Schizophrenia) - Forecast and Market Analysis to 2022 Summary Schizophrenia is a persistent long-term brain disorder that causes severe, debilitating psychotic episodes. Its core symptoms, auditory or visual hallucinations, are often accompanied by fixed, false, and often paranoid beliefs, ...

Industries: Pathology | Countries: Germany, Spain, Italy, France, Japan, World, Europe, United States, United Kingdom

Risperdal (Schizophrenia) - Forecast and Market Analysis to 2022

Risperdal (Schizophrenia) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • by Global Data
  • February 2014
  • 44 pages

Risperdal (Schizophrenia) - Forecast and Market Analysis to 2022 Summary Schizophrenia is a persistent long-term brain disorder that causes severe, debilitating psychotic episodes. Its core symptoms, auditory or visual hallucinations, are often accompanied by fixed, false, and often paranoid beliefs, ...

Industries: Pathology | Countries: Spain, Italy, France, Germany, Japan, World, United States, United Kingdom, Europe

Aripiprazole Lauroxil (Schizophrenia) - Forecast and Market Analysis to 2022

Aripiprazole Lauroxil (Schizophrenia) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • by Global Data
  • February 2014
  • 60 pages

Aripiprazole Lauroxil (Schizophrenia) - Forecast and Market Analysis to 2022 Summary Schizophrenia is a persistent long-term brain disorder that causes severe, debilitating psychotic episodes. Its core symptoms, auditory or visual hallucinations, are often accompanied by fixed, false, and often paranoid ...

Industries: Pathology | Countries: Spain, Italy, France, Germany, Japan, World, United States, United Kingdom, Europe

Cariprazine (Schizophrenia) - Forecast and Market Analysis to 2022

Cariprazine (Schizophrenia) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • by Global Data
  • February 2014
  • 60 pages

Cariprazine (Schizophrenia) - Forecast and Market Analysis to 2022 Summary Schizophrenia is a persistent long-term brain disorder that causes severe, debilitating psychotic episodes. Its core symptoms, auditory or visual hallucinations, are often accompanied by fixed, false, and often paranoid beliefs, ...

Industries: Pathology | Countries: Spain, Italy, France, Germany, Japan, World, United States, United Kingdom, Europe

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 917 267 7886

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.